The Consumer Affairs Agency in Japan authorized the use of 600mg/d of ApplePhenon for people with relatively high BMI for the reduction of abdominal fat.
BGG World (BGG; Tokyo) obtained a “Foods with Functional Claims” health claim for ApplePhenonin Japan. The Consumer Affairs Agency authorized the use of 600mg/d of ApplePhenon for people with relatively high BMI with the following wording:
“This product contains procyanidins derived from apples. The procyanidins from apples are reported to reduce relatively high BMI by supporting the decrease of body weight, body fat, visceral fat, waist circumference, and belly fat (total abdominal fat). This product is suitable for people with relatively high BMI."
“At BGG we previously obtained a claim to market ApplePhenon in Japan for skin whitening,” said Yanmei Li, PhD, global chief scientific officer of BGG, in a press release. “In South Korea, we experienced a huge success with a weight-loss claim, and we hope with this new claim for belly fat (total abdominal fat) to replicate this success, offering our customers another highly appealing claim to support their activities in our top market—Japan.”
ApplePhenon has been clinically validated for weight management, for supporting cardiovascular health, in the management of healthy glucose levels, for skin health and skin liver spots, for dental care, for respiratory support, and in the sports and endurance category.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.